威高骨科
(688161)
| 流通市值：117.28亿 | | | 总市值：117.28亿 |
| 流通股本：4.00亿 | | | 总股本：4.00亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 740,917,209.72 | 290,185,005.08 | 1,452,715,790.19 | 1,083,278,467.47 |
| 营业收入 | 740,917,209.72 | 290,185,005.08 | 1,452,715,790.19 | 1,083,278,467.47 |
| 二、营业总成本 | 562,087,567.47 | 235,809,633.56 | 1,193,304,728.68 | 909,362,061.83 |
| 营业成本 | 248,195,913.11 | 105,406,408.4 | 497,838,010.75 | 382,759,040.67 |
| 税金及附加 | 10,679,772.97 | 4,202,950.37 | 18,062,135.06 | 12,457,012.38 |
| 销售费用 | 196,274,711.36 | 83,171,306 | 480,836,119.2 | 371,892,305.06 |
| 管理费用 | 56,226,364.51 | 20,030,911.84 | 92,378,796.45 | 64,551,696.77 |
| 研发费用 | 58,209,611.09 | 28,643,022.81 | 119,904,588.25 | 91,157,022.54 |
| 财务费用 | -7,498,805.57 | -5,644,965.86 | -15,714,921.03 | -13,455,015.59 |
| 其中:利息费用 | 53,124.22 | 35,953.05 | 1,041,884.62 | 223,771 |
| 其中:利息收入 | 9,347,435.11 | 5,932,529.56 | 18,010,682.1 | 15,616,496.92 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,293,498.22 | 221,249.32 | 317,350.7 | 88,219.18 |
| 加:投资收益 | 14,943,618.92 | 7,580,071.67 | 26,784,454.93 | 19,653,093.07 |
| 资产处置收益 | - | - | 6,373,713.49 | -124,113.08 |
| 资产减值损失(新) | -25,992,797.73 | -57,089.14 | -39,993,874.05 | -12,488,219.36 |
| 信用减值损失(新) | -1,093,991.67 | 3,619,674.74 | 7,416,938.89 | 10,335,866.43 |
| 其他收益 | 7,361,134.58 | 3,371,676.57 | 11,390,976.02 | 9,228,735.98 |
| 四、营业利润 | 175,341,104.57 | 69,110,954.68 | 271,700,621.49 | 200,609,987.86 |
| 加:营业外收入 | 45,764.8 | 93,744.81 | 255,326.49 | 307,683.81 |
| 减:营业外支出 | 506,226.5 | 448,449.29 | 1,014,689.68 | 860,676.51 |
| 五、利润总额 | 174,880,642.87 | 68,756,250.2 | 270,941,258.3 | 200,056,995.16 |
| 减:所得税费用 | 30,249,174.23 | 16,208,143.52 | 42,656,131.73 | 31,630,383.5 |
| 六、净利润 | 144,631,468.64 | 52,548,106.68 | 228,285,126.57 | 168,426,611.66 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 144,631,468.64 | 52,548,106.68 | 228,285,126.57 | 168,426,611.66 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 141,957,058.61 | 51,789,016.82 | 223,751,739.09 | 164,293,158.99 |
| 少数股东损益 | 2,674,410.03 | 759,089.86 | 4,533,387.48 | 4,133,452.67 |
| 扣除非经常损益后的净利润 | 135,796,706.88 | 49,066,897.23 | 210,870,055.19 | 159,306,719.77 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.35 | 0.13 | 0.56 | 0.41 |
| (二)稀释每股收益 | 0.35 | 0.13 | 0.56 | 0.41 |
| 九、综合收益总额 | 144,631,468.64 | 52,548,106.68 | 228,285,126.57 | 168,426,611.66 |
| 归属于母公司股东的综合收益总额 | 141,957,058.61 | 51,789,016.82 | 223,751,739.09 | 164,293,158.99 |
| 归属于少数股东的综合收益总额 | 2,674,410.03 | 759,089.86 | 4,533,387.48 | 4,133,452.67 |
| 公告日期 | 2025-08-28 | 2025-04-30 | 2025-03-27 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |